Aptevo Therapeutics Price to Book Ratio 2014-2021 | APVO

Historical price to book ratio values for Aptevo Therapeutics (APVO) over the last 10 years. The current price to book ratio for Aptevo Therapeutics as of October 22, 2021 is 4.57.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Aptevo Therapeutics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 14.25 5.01
2021-06-30 22.43 $2.84 7.89
2021-03-31 30.52 $2.36 12.93
2020-12-31 36.65 $3.76 9.74
2020-09-30 7.60 $0.68 11.16
2020-06-30 8.35 $2.68 3.12
2020-03-31 3.70 $4.69 0.79
2019-12-31 9.16 $3.66 2.50
2019-09-30 8.24 $6.11 1.35
2019-06-30 12.41 $8.14 1.53
2019-03-31 12.60 $12.15 1.04
2018-12-31 17.78 $18.67 0.95
2018-09-30 71.12 $27.17 2.62
2018-06-30 69.86 $34.62 2.02
2018-03-31 45.78 $42.67 1.07
2017-12-31 59.36 $53.18 1.12
2017-09-30 32.06 $59.03 0.54
2017-06-30 28.98 $33.80 0.86
2017-03-31 28.84 $40.58 0.71
2016-12-31 34.16 $34.94 0.98
2016-09-30 35.84 $44.10 0.81
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.070B $0.004B
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76